TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients

This study has been completed.

Study NCT00071097 Information provided by Tibotec Pharmaceuticals, Ireland

First Received: October 10, 2003 Last Updated: October 2, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2007
Primary Completion Date:	November 2007 (Final data collection date for primary outcome measure)